Specialty Pharmacy

Gilotrif shows significant reduction in the risk of adenocarcinoma progression.

Under expanded agreements, pharmacists can establish agreements with multiple physicians in order to manage drug therapy for multiple patients.

Inherited genetic variations leave acute lymphoblastic leukemia patients sensitive to drugs and at risk for toxicity.

Researchers apply a dynamic model to analyze demand response to non-linear drug benefits using data from Medicare Part D.

New option approved for liver transplant patients and individuals with decompensated cirrhosis.

Scarring on the brain from MS can impact the ability to identify certain flavors.

Electronic prescribing systems can influence prescriber behavior and may result in lower prescription medication costs.

Enhanced tumor analysis can help identify individual therapeutic cancer strategies.

David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, discusses the benefits of MedImpact's iRx program.

Large proportion of high risk young adults are unaware they are infected with HIV.

Vinegar works to suppress inflammation-inducing proteins while improving the gut’s bacterial makeup.

The annual cost to the Medicare system for IPF is estimated to be $1 billion annually.

Many consumers are spending more than necessary as a result of choosing the wrong health insurance plan.

Issues with learning and paying attention associated with intensive chemotherapy for leukemia.

RNA-based drug infiltrates the virus to prevent HIV from replicating.

MS is difficult to diagnose because progression of the disease occurs at different rates.

Consuming less dietary cholesterol may reduce mortality or transplantation in women with hepatitis C.

Durvalumab and tremelimumab demonstrated antitumor activity in patients with non-small cell lung cancer regardless of PD-L1 status.

Major depressive disorder is the leading cause of disability among adults in high-income countries.

Specialty benefit design and management tools employed by pharmacy benefit managers can help control specialty drug spending and ensure optimal patient care.

Released prisoners given continued medication access are more likely to avoid re-arrests.

Numerous canine breeds develop cancers such as breast cancer and melanoma that have genetic similarities with the human equivalent disease.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses the implications of rising drug costs on specialty pharmacy.

Treatment can cause new blood vessel formation by activating signaling pathways.

Independents grapple with increasingly aggressive policies among payers, pharmacy benefit managers, and pharma companies.

Adenosine deaminase could help activate the immune system to rapidly fight and eliminate HIV.

Certain lots of SyrSpend SF and SyrSpend SF Grape suspending agents recalled due to the presence of yeast.

Despite the fact that the oral cavity and the lower airways are directly connected, the relationship between the two is not well understood.